The use of vacuum-assisted closure in Fournier’s gangrene

Year 2021, Volume: 7 Issue: 2, 203 - 208, 04.03.2021

Özer Özlü , Abdulkadir Başaran , Feyzi Kurt

https://doi.org/10.18621/eurj.809340

Cited By: 1

Abstract

Objectives: Fournier’s gangrene is an emergency surgical disease which develops and progresses rapidly and there is high risk of mortality with a delay in diagnosis and treatment. The objective of this study is to investigate the impact of vacuum-assisted closure on the clinical outcome in the treatment of Fournier’s gangrene.

Methods: A total of 28 patients diagnosed as Fournier’s gangrene and admitted to our hospital from January 2010 to December 2018 are included in this retrospective study. The diagnosis was established on the basis of physical examination. Epidemiological data including gender, age, and presence of diabetes mellitus, clinical outcomes including use of vacuum-assisted closure, length of admittance, the number of debridement and other surgical procedures were evaluated retrospectively from the medical records and the hospital treatment registry.

Results: There were 16 (57.1%) male and 12 (42.9%) female patients and the mean age of the patients was 59.54 ± 16.76 years. The mean number of debridement was 3.67 ± 1.5 times and the total hospital stay was 26.67 ± 7.7 days for vacuum-assisted closure group (n = 9). The average number of debridement was 4.11 ± 0.94 times and the total hospital stay was 31.58 ± 6.33 days for the rest of the patients (n = 19).

Conclusions: The average number of debridement and hospital stay were lower in patients treated with vacuum-assisted closure. We also observed an increase in patient comfort and the workload of the stuff is decreased as there was less exudate in the vacuum-assisted closure group.

Keywords

Fournier’s gangrene, Vacuum-assisted closure, Diabetes, Hospital stay

References

• 1. Fournier JA. Gangrene foudroyante de la verge. Med Pract 1883;4:589-97.
• 2. Eke N. Fournier`s gangrene: a review of 1726 cases. Br J Surg 2000;87:718-28.
• 3. Thwaini A, Khan A, Malik A, Cherian J, Barua J, I Shergill I, et al. Fournier`s gangrene and its emergency management. Postgrad Med J 2006;82:516-9.
• 4. Czymek R, Schmidt A, Eckmann C, Bouchard R, Wulff B, Laubert T, et al. Fournier`s gangrene: vacuum assisted closure versus conventional dressing. Am J Surg 2009;187:168-76.
• 5. Morpurgo E. Galandiuk S. Fournier`s gangrene. Surg Clin N Am 2002;82:1213-24.
• 6. Yanar H. Taviloglu K. Ertekin C, Guloglu R, Zorba U, Cabioglu N, et al. Fournier`s gangrene: risk factors and strategies for management. Word J Surg 2006;30:1750-4.
• 7. Furr J, Watts T, Street R, Cross B, Slobodov G, Patel S. Contemporary trends in the inpatient management of Fournier`s gangrene: predictors of length of stay and mortality based on population-based sample. Urology 2016;102:79-84.
• 8. Angelis S, Apostolopoulos AP, Kosmas L, Balfousias T, Papanikolaou A. The use of vacuum closure-assisted device in the management of compound lower limb fractures with massive soft tissue damage. Cureus 2019;11:e5104.
• 9. Morykwas MJ, Simpson J, Punger K, Argenta A, Kremers L, Argenta J: Vacuum-assisted closure: state of basic research and physiologic foundation. Plast Reconstr Surg 2006;117:121-6.
• 10. Oguz A, Gumus M, Turkoglu A, Bozdag Z, Ulger BV, Agacayak E, et al. Fournier’s gangrene: a summary of 10 years of clinical experience. Int Surg 2015;5:934-41.
• 11. Heiner JD, Baldwin K, Laselle B. Fournier gangrene: rapid diagnosis with bedside ultrasonography. CJEM 2010;12:528-9.
• 12. Erdogan A, Aydogan I, Senol K, Uckan EM, Ersoz S, Tez M. Simple scoring system for prediction of mortality in Fournier `s gangrene. Eur J Trauma Emerg Surg 2016;42:513-8.
• 13. Korkut M, Icoz G, Dayangac M, Akgun E, Yeniay L, Erdogan O, et al. Outcome analysis in patients with Fournier`s gangrene: report of 45 cases. Dis Colon Rectum 2003;46:649-52.
• 14. Norton KS, Johnson LW, Perry T, Perry KH, Sehon JK, Zibari GB. Management of Fournier`s gangrene: an eleven year retrospective analysis of early recognition, diagnosis, and treatment. Am Surg 2002;68:709-13.
• 15. Canbaz H, Caglikulekci M, Altun U, Dirlik M, Turkmenoglu O, Tasdelen B, et al. Fournier`s gangrene : analysis of risk factors affecting the prognosis and cost of therapy in 18 cases. Ulus Travma Acil Cerrahi Derg 2010;16:71-6.
• 16. Yılmazlar T, Isık O, Ozturk E, Ozer A, Gulcu B, Ercan I. Fournier`s gangrene: Review of 120 patients and predictors of mortality. Ulus Travma Acil Cerrahi Derg 2014;20:333-7.
• 17. Mallikarjuna MN, Vijayakumar A, Patil VS, Shivswamy BS. Fournier`s gangrene: current practices. ISRN Surg 2012:2012:942437.
• 18. Smith GL, Bunker CB, Dinneen MD. Fournier`s gangrene. Br J Urol 1998;81:347-55.
• 19. Benjelloun EB, Souiki T, Yakla N, Ousadden A, Mazaz K, Louchi A, et al. Fournier`s gangrene: our experience with 50 patients and analysis of factors affecting mortality. World J Emerg Surg 2013;8:13.
• 20. Assenza M, Cozza V, Sacco E, Clementi I, Tarantino B, Passafiume F, et al. VAC treatment in Fournier`s gangrene: personal experience and literature review. Clin Ter 2011:162:e1-5.
• 21. Cuccia G, Mucciardi G, Morgia G, d’Alcontres FS, Gali A, Cotrufo S, et al. Vacuum-assisted closure for the treatment of Fournier`s gangrene. Urol Int 2009;82:426-31.
• 22. Durmish Y, Gervaz P, Bühler L, Bucher P, Zufferey G, Al-Mazrouei A, et al. Vacuum –assisted closure: its role in the treatment of complex abdominal and perineal wounds. J Chir 2007:144:209-13.
• 23. Ugur M, Oruc C, Yıldız I, Koca YS, Daban U. The role of co-administration of damage control surgery and vacuum-assisted closure in the treatment of perineal wounds. Turk J Surg 2018;34:229-30.
• 24. Lohsiriwat V. Persistent perineal sinus: incidence, pathogenesis, risk factors and management. Surg Today 2009;39:189-93.
• 25. Liu Z, Dumville JC, Hinchliffe RJ, Cullum N, Game F, Stubbs N, et al. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Cochrane Database Syst Rev 2018;10:CD010318.
• 26. Yucel M, Ozpek A, Basak F, Kilic A, Unal E, Yuksekdag S, et al. Fournier`s gangrene: a retrospective analysis of 25 patients. Ulus Travma Acil Cerrahi Derg 2017;23:400-4.
• 27. Wagner S, Greco F, Hoda MR, Kawan F, Heynemann H, Fornara P. Is intensive multimodality therapy the best treatment for Fournier gangrene? Evaluation of clinical outcome and survival rate of 41 patients. Surg Infect (Larchmt) 2011;12:379-83.
• 28. Chennamsetty A, Khourdaji I, Burks F, Killinger KA. Contemporary diagnosis and management of Fournier's gangrene. Ther Adv Urol 2015;7:203-15.